Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Casma Therapeutics
38 Sidney Street, Suite 200
Cambridge, MA 02139
Phone: 857-777-4990
https://www.casmatx.com/

Casma Therapeutics is harnessing the natural cellular process of autophagy to open vast new target areas for drug discovery and development. Casma uses several approaches to intervene at strategic points throughout the autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens. By boosting autophagy, Casma expects to be able to arrest or reverse the progression of lysosomal storage disorders, muscle disorders, inflammatory disorders and neurodegeneration, among other indications.

Key Contact
Name
Keith Dionne, Ph.D.
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
05/03/18 $58,500,000 Series A Third Rock Ventures
undisclosed
09/10/20 $50,000,000 Series B Eventide Asset Management
Schroder Adveq
The Column Group
Third Rock Ventures
undisclosed
11/15/22 $46,000,000 Series C Amgen Ventures
Astellas Venture Management
Eisai
Euclidean Capital
Eventide Asset Management
Mirae Asset Capital
Ono Venture Investment
Schroders Capital
The Column Group
Third Rock Ventures
undisclosed